Maribavir

Maribavir is a prescription antiviral medicine used to treat cytomegalovirus (CMV) infection in people who have had a stem cell transplant. It is used to treat an active CMV infection that is not responding to other treatments. It works by blocking the virus from replicating and spreading, which helps to reduce the severity of the infection. Maribavir is usually taken once daily for up to 28 days. Common side effects include nausea, diarrhea, and headache.

Maribavir, sold under the brand name Livtencity, is an antiviral medication specifically used to treat a resistant form of cytomegalovirus (CMV) infection. Here's a breakdown of its key points:

What it treats:

• Targets CMV infection in people who have undergone organ transplantation (either hematopoietic stem cell transplant or solid organ transplant).
• Crucially, it's for situations where standard treatments fail: Maribavir is only used when other medications like ganciclovir, valganciclovir, cidofovir, or foscarnet haven't been effective in controlling the CMV infection.

How it works:

• Maribavir belongs to a class of drugs called CMV pUL97 kinase inhibitors.
• It works by targeting a specific enzyme (pUL97 kinase) essential for CMV replication within the host cells. By inhibiting this enzyme, Maribavir disrupts the virus's ability to multiply and spread.

Important Considerations:

• Maribavir is a prescription medication and should only be taken under a doctor's supervision.
• It has approval for use in adults and children over 12 years old who meet the weight criteria (at least 35 kg or 77 lbs). (Approval details may vary depending on the region).
• Common side effects include taste disturbance, nausea, diarrhea, vomiting, and fatigue.
• There can also be drug interactions, so it's vital to inform your doctor about all medications you take before starting Maribavir.